CPHL · Citi Pharma Ltd.
Citi Pharma Receives CCP Authorization for Acquisition of Pakheim International Pharma
Official PSX filing title: Material Information
- Filed
- 19 October 2026 at 8:05 am
- Category
- Material
- Sentiment
- Good
- Impact
- High
Executive summary
Citi Pharma Limited has received authorization from the Competition Commission of Pakistan (CCP) dated October 9, 2026, to acquire 100% shareholding of Pakheim International Pharma (Private) Limited. The acquisition will proceed in accordance with the Share Purchase Agreement dated May 6, 2026, pending completion of other formalities.
Key takeaways
- Received CCP authorization for 100% acquisition of Pakheim International Pharma (Private) Limited
- Order issued by CCP on October 9, 2026
- Transaction follows the Share Purchase Agreement dated May 6, 2026
- #acquisition
- #ccp
- #pakheim
- #cphl
- #material_information
Please cross-check with the official PSX filing before making an investment decision.